Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

New chief investor of Ivy Investment Group calls it right on OREX

|Includes: Orexigen Therapeutics, Inc. (OREX)

My best decision, thus far, has been to put somebody else smarter than me in charge of my investment group.  Rowan Jenkins, chief investor of Ivy Investment Group, called OREX (Orexigen Therapeutics, Inc.) at the bounce perfectly.  The stock has been rising at a healthy pace over the past few days.  He says to sell at $6.49 or $7.00.

This stock wasn't on anyone's radar.  He sifted and informed our investors well in advance for them to make a profit before anyone else.  This is just the beginning of a new era of our dominance in the investment community.  If you want to be a part of this, join Ivy Investment Group today www.theivyinvestmentgroup.com the #1 investment group on the internet!


happy huntin',

Maurice Ivy
Senior Partner
Ivy, Whitfield, and Associates, G.P.
www.ivy-whitfield.com



Disclosure: Long OREX